Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Easy Mark who wrote (307)	3/25/1998 5:34:00 PM
From: Robert DeHaven	Read Replies (1) \| Respond to of 1510

Correct: No insider sales....let us remember that last May Kevin Kimberlin (Dir) bought 1,776,004 shares at $7.80 bringing his holdings to 2,070,920 and Dennis Carlo bought 253,715 shares bringing his holding to 448,048 shares. I like the fact these guys put up money in their own company. Ilike the fact Capital Guardian Trust owns 1,420,000 shares and State Farm 884,000 shares...... I like the fact IMNR did not participate in the drubbing drugs took today....... Shall I go on.......? Here's my thought today...... There are many who will buy this company IF they can actually get a corporate partnership on some important businesses such as; Gene Therapy, Rheumatoid Arthritis and Remune. I have heard that they will not partner Remune though....that's the crown jewel. I remain very optimistic...but impatient....parterships have long been expected. good luck, bob